Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patientsJonathan S. Zager, Pedram Gerami, Martin D. Fleming et al.|BMC Cancer|2018Cited by 142
A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary reportS. Kim, Andrew S. Brohl, Nikhil I. Khushalani et al.|Annals of Oncology|2019Cited by 5